Navamedic ASA (NAVA)

Currency in NOK
25.60
-0.40(-1.54%)
Closed·
NAVA Scorecard
Full Analysis
High shareholder yield
NAVA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25.2026.30
52 wk Range
17.1033.50
Key Statistics
Prev. Close
26
Open
26.2
Day's Range
25.2-26.3
52 wk Range
17.1-33.5
Volume
5.34K
Average Volume (3m)
13.97K
1-Year Change
-21.69%
Book Value / Share
12.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NAVA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
34.00
Upside
+32.81%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Navamedic ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Navamedic ASA Company Profile

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases, fat metabolism, renal, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women’s health, and others primarily through pharmacies and drugstores; prescription medicines covering obesity, Parkinson’s disease, urology, and cardiology; and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is based in Oslo, Norway.

Employees
42
Market
Norway

Compare NAVA to Peers and Sector

Metrics to compare
NAVA
Peers
Sector
Relationship
P/E Ratio
−42.4x5.0x−0.5x
PEG Ratio
-0.010.00
Price/Book
2.2x2.9x2.6x
Price / LTM Sales
0.9x2.4x3.2x
Upside (Analyst Target)
29.8%33.7%42.7%
Fair Value Upside
Unlock2.0%5.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 34.00
(+32.81% Upside)

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-0.07 / 0.50
Revenue / Forecast
132.02M / 132.00M
EPS Revisions
Last 90 days

NAVA Income Statement

FAQ

What Stock Exchange Does Navamedic Trade On?

Navamedic is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Navamedic?

The stock symbol for Navamedic is "NAVA."

What Is the Navamedic Market Cap?

As of today, Navamedic market cap is 452.17M.

What Is Navamedic's Earnings Per Share (TTM)?

The Navamedic EPS (TTM) is 0.00.

When Is the Next Navamedic Earnings Date?

Navamedic will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is NAVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Navamedic Stock Split?

Navamedic has split 1 times.

How Many Employees Does Navamedic Have?

Navamedic has 42 employees.

What is the current trading status of Navamedic (NAVA)?

As of 23 Jul 2025, Navamedic (NAVA) is trading at a price of 25.60, with a previous close of 26.00. The stock has fluctuated within a day range of 25.20 to 26.30, while its 52-week range spans from 17.10 to 33.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.